JULIAN
CARRETERO ASUNCION
TITULAR DE UNIVERSIDAD
Fondazione IRCCS Istituto Nazionale dei Tumori
Milán, ItaliaPublicaciones en colaboración con investigadores/as de Fondazione IRCCS Istituto Nazionale dei Tumori (2)
2017
-
Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition
Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3203-3213
2015
-
PARD3 inactivation in lung squamous cell carcinomas impairs STAT3 and promotes malignant invasion
Cancer Research, Vol. 75, Núm. 7, pp. 1287-1297